Wei‐Fu Lv
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
Papers in
- Hepatology 28
- Liver Disease and Transplantation 16
- Hepatocellular Carcinoma Treatment and Prognosis 14
- Surgery 17
- Organ Transplantation Techniques and Outcomes 9
- Co-authors
- Chunze Zhou (18 shared papers)Ping Xu (2 shared papers)Wei Wei (1 shared paper)Dong Lu (10 shared papers)Wenjing Tang (2 shared papers)Yusheng He (1 shared paper)Yucai Wang (3 shared papers)Ruifeng Wang (4 shared papers)
In The Last Decade
Wei‐Fu Lv
49 papers receiving 593 citations
Peers
Comparison fields: 5 of 83
- Hepatology 180
- Infectious Diseases 129
- Radiology, Nuclear Medicine and Imaging 154
- Health Informatics 8
- Critical Care and Intensive Care Medicine 22
Countries citing papers authored by Wei‐Fu Lv
This map shows the geographic impact of Wei‐Fu Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Fu Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Fu Lv more than expected).
Fields of papers citing papers by Wei‐Fu Lv
This network shows the impact of papers produced by Wei‐Fu Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Fu Lv. The network helps show where Wei‐Fu Lv may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei‐Fu Lv, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 168 | |
| 2 | 2016 | 41 | |
| 3 | 2022 | 38 | |
| 4 | 2021 | 26 | |
| 5 | 2018 | 22 | |
| 6 | Prognostic factors for acute kidney injury following transarterial chemoembolization in patients with hepatocellular carcinoma. | 2014 | 21 |
| 7 | Predictive accuracy comparison of MELD and Child-Turcotte-Pugh scores for survival in patients underwent TIPS placement: a systematic meta-analytic review. | 2015 | 21 |
| 8 | 2022 | 18 | |
| 9 | 2019 | 18 | |
| 10 | 2015 | 17 | |
| 11 | 2020 | 16 | |
| 12 | 2019 | 14 | |
| 13 | 2018 | 14 | |
| 14 | 2024 | 13 | |
| 15 | 2017 | 12 | |
| 16 | 2023 | 11 | |
| 17 | 2015 | 11 | |
| 18 | 2019 | 10 | |
| 19 | 2023 | 9 | |
| 20 | 2018 | 8 |
About Wei‐Fu Lv
Wei‐Fu Lv is a scholar working on Hepatology, Surgery, Pulmonary and Respiratory Medicine, Epidemiology and Pathology and Forensic Medicine, having authored 51 papers that have together received 607 indexed citations. Recurring topics across this work include Liver Disease and Transplantation (16 papers), Hepatocellular Carcinoma Treatment and Prognosis (14 papers), Liver Disease Diagnosis and Treatment (11 papers), Organ Transplantation Techniques and Outcomes (9 papers), Cancer Mechanisms and Therapy (6 papers), Gallbladder and Bile Duct Disorders (4 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Radiomics and Machine Learning in Medical Imaging (4 papers). The work is most often cited by research in Hepatology (180 citations), Infectious Diseases (129 citations), Radiology, Nuclear Medicine and Imaging (154 citations), Health Informatics (8 citations) and Critical Care and Intensive Care Medicine (22 citations). Wei‐Fu Lv has collaborated with scholars based in China, Australia and Japan. Frequent co-authors include Chunze Zhou, Ping Xu, Wei Wei, Dong Lu, Wenjing Tang, Yusheng He, Yucai Wang, Ruifeng Wang, Wei Jiang and Zhengfeng Zhang. Their work appears in journals such as Hepatology International, Drug Design Development and Therapy, Journal of Clinical Oncology, CardioVascular and Interventional Radiology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.